PE20020731A1 - 6-HYDROXY-8- [4- [4- (2-PYRIMIDINYL) -PIPERAZINYL] -BUTYL] -8-AZASPIRO [4.5] -7,9-DIONA - Google Patents
6-HYDROXY-8- [4- [4- (2-PYRIMIDINYL) -PIPERAZINYL] -BUTYL] -8-AZASPIRO [4.5] -7,9-DIONAInfo
- Publication number
- PE20020731A1 PE20020731A1 PE2001000056A PE2001000056A PE20020731A1 PE 20020731 A1 PE20020731 A1 PE 20020731A1 PE 2001000056 A PE2001000056 A PE 2001000056A PE 2001000056 A PE2001000056 A PE 2001000056A PE 20020731 A1 PE20020731 A1 PE 20020731A1
- Authority
- PE
- Peru
- Prior art keywords
- diona
- azaspiro
- pyrimidinyl
- hydroxy
- piperazinyl
- Prior art date
Links
- AFNJMVYFZNHDRX-UHFFFAOYSA-N [C]1=NC=CC=N1 Chemical class [C]1=NC=CC=N1 AFNJMVYFZNHDRX-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- KOZNAHJIJGCFJJ-UHFFFAOYSA-N 6-hydroxy buspirone Chemical compound O=C1CC2(CCCC2)C(O)C(=O)N1CCCCN(CC1)CCN1C1=NC=CC=N1 KOZNAHJIJGCFJJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- QWCRAEMEVRGPNT-UHFFFAOYSA-N buspirone Chemical class C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 QWCRAEMEVRGPNT-UHFFFAOYSA-N 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000007910 systemic administration Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A LA ADMINISTRACION SISTEMICA DE UNA DOSIS ANSIOLITICA EFECTIVA PERO NO TOXICA DEL COMPUESTO 6-HIDROXI-8-[4-[4-(2-PIRIMIDINIL)-PIPERAZINIL]-BUTIL]-8-AZASPIRO[4.5]-7,9-DIONA DE FORMULA I (METABOLITO ACTIVO DE LA BUSPIRONA) O UNA SAL DE ADICION DE ACIDO O HIDRATO. EL COMPUESTO MENCIONADO ES BMY 28674 Y ES UTIL PARA EL TRATAMIENTO DE LA ANSIEDADREFERS TO THE SYSTEMIC ADMINISTRATION OF AN EFFECTIVE BUT NON-TOXIC ANSIOLYTIC DOSE OF THE COMPOUND 6-HYDROXY-8- [4- [4- (2-PYRIMIDINYL) -PIPERAZINIL] -BUTIL] -8-AZASPIRO [4.5] -7.9 -DIONA OF FORMULA I (ACTIVE METABOLITE OF BUSPIRONE) OR A SALT OF ADDITION OF ACID OR HYDRATE. THE COMPOUND MENTIONED IS BMY 28674 AND IS USEFUL FOR THE TREATMENT OF ANXIETY
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48416100A | 2000-01-18 | 2000-01-18 | |
| US09/588,221 US6150365A (en) | 1999-08-05 | 2000-06-06 | Anxiety method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020731A1 true PE20020731A1 (en) | 2002-08-11 |
Family
ID=32851129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000056A PE20020731A1 (en) | 2000-01-18 | 2001-01-18 | 6-HYDROXY-8- [4- [4- (2-PYRIMIDINYL) -PIPERAZINYL] -BUTYL] -8-AZASPIRO [4.5] -7,9-DIONA |
Country Status (2)
| Country | Link |
|---|---|
| PE (1) | PE20020731A1 (en) |
| ZA (1) | ZA200204824B (en) |
-
2001
- 2001-01-18 PE PE2001000056A patent/PE20020731A1/en not_active Application Discontinuation
-
2002
- 2002-06-14 ZA ZA200204824A patent/ZA200204824B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200204824B (en) | 2004-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2436780C2 (en) | 5-phenylthiazole derivatives and use thereof as pi3 kinase inhibitors | |
| TR200401644T4 (en) | Substituted sulfonylaminomethylbenzoic acid (derivatives) and manufacturing methods | |
| BR0114870A (en) | Treatment of gastrointestinal stromal tumors | |
| TR200000060T2 (en) | Crystal modification of a N-phenyl-2-pyrimidinamine derivative and its construction processes and use. | |
| NO20066041L (en) | Use of substituted quinoline derivatives for the treatment and drug-resistant mycobacterial diseases | |
| RU2003114752A (en) | TREATMENT OF GASTROINTESTINAL STOMAL TUMORS | |
| EA200200087A1 (en) | REPLICATION INHIBITORS OF RESPIRATORY-SYNCTIAL VIRUS | |
| NO20081482L (en) | Delta and epsilon crystal forms for imatinib mesylate | |
| AR050918A1 (en) | SOLUTION FOR INFUSION OF DIHYDROPTERIDINONES STABILIZED FOR STORAGE | |
| NO20060973L (en) | Pyridyl derivatives and their use as tempeutic agents | |
| DOP2000000114A (en) | SUBSTITUTED OXAZOLIDINONES AND ITS USE | |
| RU2013132930A (en) | Pyrazole derivative | |
| TR200401029T4 (en) | Acylphenyl-urea derivatives, manufacturing methods and their use as pharmaceuticals | |
| NO20024177L (en) | Pharmaceutical preparations containing azetidine derivatives, the new azetidine derivatives and their preparation | |
| DK1200426T3 (en) | Substituted thien-3-yl-sulfonylamino (thio) carbonyl-thiazoline (thi) ones | |
| NO20062905L (en) | Novel hydroxamic acid esters and their pharmaceutical use | |
| HRP20020404B1 (en) | SOLUTIONS CONTAINING EPINASTINE | |
| RU2007101236A (en) | NEW HYDANTOINE DERIVATIVES FOR TREATMENT OF OBSTRUCTIVE RESPIRATORY DISEASES | |
| AR065850A1 (en) | SOLID PHARMACEUTICAL COMPOSITION INCLUDING A BENZIMIDAZOL-7-CARBOXYLATE DERIVATIVE AND A PH CONTROL AGENT | |
| EA200971086A1 (en) | PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING SCHIZOPHRENIA | |
| NO20043115L (en) | Substituted diketopiperazines as oxytocin antagonists | |
| SE9903831D0 (en) | Formulation of substituted benzimidazoles | |
| ATE361918T1 (en) | 4-(4-METHOXYBENZYL)-N'-(5-NITRO-1,3-THIAZOL-2-YL)UREA AND ITS USE IN THE TREATMENT OF GLYCOGEN SYNTHASE KINASE-3 (GSK3)-ASSOCIATED CONDITIONS | |
| BR0113062A (en) | Heterocyclylalkylazole derivatives and their use as a parasite control agent | |
| SE0002476D0 (en) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |